Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)
Shung Wu(Bristol-Myers Squibb (United States)), Jeffrey A. Robl(Bristol-Myers Squibb (Germany)), Marianne B. Vath(Bristol-Myers Squibb (Germany)), Ramakrishna Seethala(Bristol-Myers Squibb (United States)), Cheryl Ferraro(Bristol-Myers Squibb (Germany)), J. Gerry Everlof(Bristol-Myers Squibb (United States)), Lori Kunselman(Bristol-Myers Squibb (United States)), Daniel M. Camac(Bristol-Myers Squibb (United States)), Janice E. Chin(Bristol-Myers Squibb (Germany)), Kasia Kieltyka(Bristol-Myers Squibb (Germany)), Nathan Morgan(Bristol-Myers Squibb (United States)), Rajasree Golla(Bristol-Myers Squibb (United States)), Tatyana Zvyaga(Bristol-Myers Squibb (Germany)), Akbar Nayeem(Bristol-Myers Squibb (United States)), Randolph Ponticiello(Bristol-Myers Squibb (United States)), S. Sheriff(Bristol-Myers Squibb (United States)), Bogdan Sleczka(Bristol-Myers Squibb (United States)), Paul E. Morin(Bristol-Myers Squibb (United States)), Bin He(Guiyang Medical University), Katy Van Kirk(Bristol-Myers Squibb (United States)), Joseph R. Taylor(Bristol-Myers Squibb (United States)), Wilson Z. Shou(Bristol-Myers Squibb (Germany)), David Yoon(Bristol-Myers Squibb (United States)), Rachel Zebo(Bristol-Myers Squibb (United States)), Mengmeng Wang(Bristol-Myers Squibb (United States)), Yixin Li(Chongqing University), Wenying Li(Huanggang Normal University), David A. Gordon(Bristol-Myers Squibb (United States)), Timothy W. Harper(Bristol-Myers Squibb (United States)), Lisa Zhang(Bristol-Myers Squibb (United States)), Thomas Harrity(Bristol-Myers Squibb (United States))
Cited by 28
Related Papers
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306